- ORAL CONTRACEPTION (Enrollment Closed)
- ANEMIA
- INTRAUTERINE DEVICE (IUD) (Enrollment Closed)
- CONTRACEPTION (TRANSDERMAL PATCH) (Enrollment Closed)
- ORAL CONTRACEPTION
- ORAL CONTRACEPTION
- HOT FLASHES
- ABNORMAL PAP SMEAR
- CONSTIPATION
- VULVOVAGINAL ATROPHY
- CONTRACEPTION (VAGINAL GEL)
ORAL CONTRACEPTION
Purpose
The primary objective of this study is to evaluate and compare bleeding patterns between three different dose extended cycle (91-day) oral contraceptive regimens.
Study Population
Females aged 18-45 years old that are not at risk for pregnancy and have an understanding and comprehension of the English language
Back to top
ANEMIA
Purpose
The main objective of this study is to demonstrate the efficacy and safety of an investigational intravenous (IV) iron, ferric carboxymaltose, (FCM) compared to oral iron in subjects who have IDA and have been shown to have an unsatisfactory response to oral iron.
Study population
Male or female subjects at least 18 years of age with hemoglobin levels of 11 g/dL or less.
Please fill out our questionnaire Click here
Back to top
INTRAUTERINE DEVICE (IUD)
Purpose
The primary objective of this study is to assess the safety, efficacy and pharmacokinetics of a new intrauterine contraceptive system administered for 3 years.
Study Population
Healthy 18 to 35 year-old nulliparous or parous females in need of contraception that are not at risk for pregnancy and have an understanding and comprehension of the English language
Back to top
CONTRACEPTION (TRANSDERMAL PATCH)
Purpose
The primary objective of this study is to evaluate the contraceptive efficacy of the transdermal contraceptive patch.
Study Population
Females aged 18-35 with a history of regular cyclic menstrual periods.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Back to top
ORAL CONTRACEPTION
Purpose
Healthy females 18 to 50 years of age (smokers with a maximum age of 35 years) that are suffering from pelvic pain or headache while using a 21-day oral contraceptive and are willing to switch their current medication to the study medication.
Study Population
Females aged 18-50 with a history of regular cyclic menstrual periods.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
ORAL CONTRACEPTION
Purpose
The primary objective is to investigate the bleeding pattern and cycle control parameters of the transdermal contraceptive patch in comparison to a combined oral contraceptive.
Study Population
Females aged 18-45 years requesting contraception, smokers with a maximum age of 35 at inclusion.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
ORAL CONTRACEPTION
Purpose
The primary objective is to demonstrate the efficacy and safety of a 91-day combination oral contraceptive regimen, utilizing ascending doses taken for 1 year in women desiring pregnancy prevention.
Study Population
Sexually active females who are at risk for pregnancy and 18-40 years of age.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
HOT FLASHES
Purpose
The primary objective is to assess the safety and efficacy of a NON-HORMONAL treatment as compared to placebo in reducing the average daily frequency and severity of hot flashes in postmenopausal women.
Study Population
Postmenopausal women 40 to 65 years of age who have been experiencing hot flashes accompanied by sweating during the previous 30 days or longer.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
ABNORMAL PAP SMEAR
Purpose
The primary objective is to assess the efficacy of a medication used to treat high grade cervical intraepithelial neoplasia (CIN) grade 2 ot 3 assocated with High Risk HPV infection
Study Population
Females 18 or more years of age who have been diagnosed with CIN 2/3 in the past 2 months.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
CONSTIPATION
Purpose
The primary objective is to evaluate the two different medications in the treatment of chronic idioopathic constipation
Study Population
Males or females aged 18 and older with a clinical diagnosis of chronic idiopathic constipation defined as on average, 3 spontaneous bowel movements per week.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
VULVOVAGINAL ATROPHY
Purpose
The primary objective is to compare the efficacy of 2 doses of an estradiol vaginal gel compared to placebo in the relief of vaginal dryness due to vulvovaginal atrophy.
Study Population
Females that no longer have menstrual cycles.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
CONTRACEPTION (VAGINAL GEL)
Purpose
The primary objective is to determine the contraceptive efficacy of two different vaginal gels.
Study Population
Sexually active females between the age of 18 to 35 that have regular cyclic menstrual periods and are at risk for pregnancy.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here
Back to top
